Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 96,986 shares at $60.11 ($5.8M) on 2021-06-18, disclosed to the SEC on 2021-06-22.
Open-market sale of $5.8M AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.11 | 48,493 | $2.9M | 50.0% |
| 2 | $60.11 | 48,493 | $2.9M | 50.0% |
| Total | $60.11 avg | 96,986 | $5.8M | 100% |
| Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |
| AGIO | SELL | 2020-05-21 | $358K | — | Filing → |